Evidence map›Paper›PMID 34072538›Full record

ReviewMolecules (Basel, Switzerland)2021

Roadside Drug Testing Approaches.

Manal A Alhefeiti, James Barker, Iltaf Shah

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Lessons Learned from Liver-on-Chip Platform.Annals of biomedical engineering · 2025
    Review
  4. Article
  5. Drug Use and Road Traffic Injuries- Shots in the Dark.Indian journal of psychological medicine · 2024
    Article
  6. Article
  7. Interpol review of toxicology 2019-2022.Forensic science international. Synergy · 2023
    Review
  8. Article
  9. Cannabis and Driving.Frontiers in psychiatry · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Manal A AlhefeitiDepartment of Chemistry, College of Science, UAE University, Al Ain P.O. Box 15551, United Arab Emirates.
James BarkerSchool of Life Sciences, Pharmacy and Chemistry, Kingston University, Surrey KT1 2EE, UK.ORCID 0000-0002-5863-9400
Iltaf ShahDepartment of Chemistry, College of Science, UAE University, Al Ain P.O. Box 15551, United Arab Emirates.ORCID 0000-0002-3739-6083
United Arab Emirates University · AEKingston University · GB

Funding

United Arab Emirates University College of Graduate Studies
6 · The paper itself

Abstract

The purpose of this review is to present an overview of roadside drug testing, driving enforcement, and drunk/drug driving detection around the world. Drunk and drug driving is a severe problem, not only in the UAE, but also around the world. This has important implications for road safety as drunk or drug driving may increase the chances of a driver's involvement in a road crash when compared to a drug-free driver. Recently, due to increases in drug-impaired drivers' crash involvement, many mobile roadside drug testing devices have been introduced to the market. These devices use oral fluid, urine or blood matrices. These are on-the-spot tests, which are easy to use and are applied by law enforcement agencies and the public. Law enforcement agencies most commonly use oral fluid to detect the presence of illicit drugs in drivers. This review discusses all the available devices in the market used by the authorities. It also describes the type of drugs widely abused by drivers along with behavioral testing methods. The different types of matrices used for roadside drug testing are also evaluated. Sample collection, storage, and pre-treatment methods are discussed, followed by the confirmatory analysis of positive samples. This article will significantly help law enforcement agencies compare and evaluate all the reliable roadside testing devices and new emerging confirmatory devices available to them in the market. This will help them make an informed decision on which device to adapt to their individual needs.

Indexed as

Point-of-Care TestingAccidents, TrafficAlcoholic IntoxicationAutomobile DrivingDriving Under the InfluenceHumansIllicit DrugsLaw EnforcementPharmaceutical PreparationsSalivaSubstance Abuse DetectionIllicit DrugsPharmaceutical Preparationsdrugs of abusedrug testingLC-MS/MSroadside testingsubstance abuse

Identifiers

PMID34072538
PMCPMC8199318
OpenAlexW3165138059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.